Be the Change. Do Something. Copyright © The Stutman Switalski Group LLC 2017
Copyright © The Stutman Switalski Group LLC 2017
Copyright © The Stutman Switalski Group LLC 2017
Copyright © The Stutman Switalski Group LLC 2017 OVERPRESCRIBING People v. Cheng UNDERPRESCRIBING Bergman v. Chin Copyright © The Stutman Switalski Group LLC 2017
Suggested Best Practices for Compliance Program: Frequently monitor your statistical prescribing habits (6 months); Keep independent log and copies of C2 prescriptions and verify against PDMP Have a policy for random patient “Pill Counts”; Observed UDS; Have a plan for violations of PMC or CSA; Refer violators to Addiction Medicine; Consider alternative therapy; Office visit every 30 days for CII patients. Policy for verifying the validity of MRI, X-Rays; Demand complete medical records prior to first visit*; Document, document, document; Align treatment with functional goals; Pain Management Contracts (PMC) or Controlled Substance Agreements (CSA); Regularly update PMC or CSA; *Some only apply to Pain Management Physicians Copyright © The Stutman Switalski Group LLC 2017
#1: PATIENT HISTORY! DEVELOP A PROTOCOL NON- DISCRIMINATORY Copyright © The Stutman Switalski Group LLC 2017
Copyright © The Stutman Switalski Group LLC 2017
2016 Journal of Addiction Medicine October 6, 2016: Under-reporting of drug use among self-reported risky drug users: Amphetamines 66% Opiates 45% Cocaine 14% Marijuana 7% Under-reporting associated with history of incarceration and older age (p<0.05) Copyright © The Stutman Switalski Group LLC 2017
#2: URINE DRUG SCREENING Copyright © The Stutman Switalski Group LLC 2017
#3: PDMP #4: PILL COUNTS Copyright © The Stutman Switalski Group LLC 2017
Copyright © The Stutman Switalski Group LLC 2017
EROWID Copyright © The Stutman Switalski Group LLC 2017